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INTRODUCTION
Cyclins have been shown to be proteins that both activate cyclin-dependent kinases and impart some degree of substrate specificity to the cyclin-CDK holoenzyme. Although very little is known about what these substrates are, it is clear that the regulation of levels of cyclins is crucial for cell cycle progression. In the yeast Saccharomyces cerevisiae several cyclins have been identified. Some, the CLNs, appear to be specific for the G1/S transition while others, the CLBs appear to be specific for the G2/M boundary. The human cyclin E gene was cloned based on its ability to complement a yeast strain with mutations in its G1 cyclin genes CLN1-3.
The cyclin E protein has subsequently been shown to be required for the G1/S transition in mammalian cells. Protein levels have been shown to cycle as the cell cycle progresses such that levels of cyclin E are maximal in early S phase and then rapidly decline. The goal of the work proposed here is to identify the components that are responsible for the regulation of the cyclin E protein levels. Such regulation has many important implications for the study of cell cycle progression and thus the onset of tumorigenesis which is an example of uncontrolled cell cycle progression. Recently, elevated levels of cyclin E protein have been correlated with severity of breast cancer.
BODY
The following three aims were approved in the Statement of Work: Specific Aim 1) Are proteins that physically interact with cyclin E protein involved in its degradation?
Specific Aim 2) Can an in vitro system for regulation of cyclin E be developed by identifying the proteins that regulate ubiquitination of cyclin E?
Specific Aim 3) Are the human homologues of the proteins that regulate yeast G1 cyclins responsible for the degradation of human cyclin E?
The first aim has been addressed during the first year of support. A yeast 2 hybrid screen was utilized to identify proteins that bind cyclin E. The results of the two hybrid screen and subsequent analysis of the protein that was identified has been accepted for publication by the journal Genes and Development and appeared in the September 15 issue.
KEY RESEARCH ACCOMPLISHMENTS (First year) * Identification of a cyclin E binding protein that is homologous to known cyclin degradation proteins * Cloning of the cul-3 gene and development of reagents to study its role in the degradation of cyclin E in cells. These reagents include antibodies, cells lines, expression vectors and knock out mice. *Extensive analysis of knock out mice (still under way).
The second aim was addressed during the second year of support. Baculo expressed cyclin E bound to its kinase CDK2 were made and the requirements for phosphorylation of cyclin E and disassociation of the complex were studied. In addition further analysis of the cul-3 protein were performed by the construction of a conditional knockout of the cul-3 gene. During the analysis of cul-3 other binding proteins were identified which led to an analysis of cul-3 binding to the CDK2 inhibitor p21. These data were published this year in Molecular Cell in February (see appended copy of paper).
KEY RESEARCH ACCOMPLISHMENTS (Second year) *Construction of a conditional knockout of the cul-3 gene in mice 92-hybrid screens using the cul-3 gene as bait to identify components of the degradation complex * development of a in vitro system to study the cyclin E-CDK2 interaction REPORTABLE OUTCOMES Part of the data obtained during the second year of support appeared in the February issue of Molecular Cell.
I am applying for a faculty position with the data reported here as the basis for my future work.
CONCLUSIONS
Based on what we have learned so far about the role of cul-3 in the degradation of cyclin E in mammalian cells we are persuing several studies to determine if cul-3 can prevent unwanted cell growth in normal organs. In addition we will use the antibodies we have developed that recognize cul-3 to analyze breast tumors samples for misregulation of cul-3 protein.
Farn) cell cycle proteins are ubiquitinated, and their deg-'University of Minnesota Cancer Center and radation is dependent upon the proteasome in vivo (King Department of Biochemistry et al., 1996a; Peters, 1998; Koepp et al., 1999; and response to stimuli such as activation of the p53 tumor required for proteasomal degradation of p21, we consuppressor (Sherr and Roberts, 1995) . p 21 meets at least structed mutant versions of p21 that were not ubiquititwo of the criteria for ubiquitin-proteasome regulation nated in vivo. Remarkably, these mutants remained in that proteasome inhibition results in both p21 accuunstable and increased in abundance upon proteamulation and appearance of p21-ubiqutin conjugates in some inhibition, indicating that direct ubiquitination of vivo (Blagosklonny et al., 1996; Maki and Howley, 1997 ; p21 is not necessary for its turnover by the protea- Cayrol and Ducommun, 1998; Rousseau et al., 1999) . some. The frequently observed correlation between Treatment of human diploid fibroblasts with two chemiprotein ubiquitination and proteasomal degradation is cally distinct proteasome inhibitors (the peptide aideinsufficient to conclude that ubiquitination is a prereqhyde MG-1 32 or the more specific proteasome inhibitor uisite for degradation.
clasto-lactacystin-13-lactone) resulted in the accumulation of endogenous p21 protein ( Figure 1A ). This was Introduction due solely to increased p21 stability. Its half-life increased from less than 30 min to greater than 2 hr (Figure The periodic expression of cell cycle proteins is a central 1 B) whereas its rate of synthesis remained unchanged feature of cell cycle control. Targeted proteolysis by ( Figure 1A) . In contrast, a radiomimetic dose of actinothe ubiquitin-proteasome system has emerged as a key mycin D, which induces p53, increased the rate of p21 determinant of this periodicity (King et al., 1996a; Peters, synthesis, but not its half-life ( Figure 1A ). 1998; Koepp et al., 1999) . Ubiquitin conjugation reguAlthough very low abundance p21-ubiquitin intermelates diverse biological systems and occurs in a series of diates can be detected in some cell types, we did not highly regulated enzymatic reactions, thereby allowing detect ubiquitinated endogenous p21 in human diploid precise substrate targeting in appropriate physiologic fibroblasts after proteasome inhibition, even though p21 contexts (Hochstrasser, 1996; Hershko and Ciechanover, was dramatically stabilized. It can be difficult to detect 1998). Several criteria are used to determine if a specific ubiquitin-protein conjugates in vivo due to rapid reprotein is degraded by the ubiquitin-proteasome system: moval of the ubiquitin chains by deubiquitinating enthe decrease in the rate of substrate turnover in cells zymes. We therefore utilized exogenously expressed caused by inhibition of the system with chemical inhibip 2 l to assess the role of ubiquitination and specific tors or by genetic mutations; detection of ubiquitin-subamino acid residues in p21 turnover. The half-life of strate conjugates in cells, usually following proteasome transfected p21 was also less than 30 min, and its abuninhibition; reconstitution of ubiquitination and/or proteadance increased by proteasome inhibition (Figures 1 C somal degradation of substrates in cell extracts in vitro; and 1 D). In this case, however, p21-ubiquitin conjugates and association of putative substrates with ubiquitinatwere readily detected (Figure 1 D) . These high-molecular ing enzymes.
weight species contained both p21 and ubiquitin as shown by their altered molecular weight when an HA 7 To whom correspondence should be addressed at the Fred Hutchepitope-tagged ubiquitin molecule was coexpressed inson Cancer Research Center (e-mail: bclurman@fhcrc.org).
with p21 (Figure 1 D) . p21 Protein that Cannot Be Ubiquitinated these six conservative substitutions ( Figure 2B ). No p 2 lRemains Unstable ubiquitin conjugates of p21 K6R were detected in vivo If p21 ubiquitination is a prerequisite for its proteasomal after proteasome inhibition in either NIH3T3 or 293 cells, turnover, then inhibition of the ubiquitination pathway even when highly overexpressed and when the film was should stabilize p21. We tested this hypothesis using overexposed ( Figure 2C and data not shown), indicating four different approaches, all of which suggested that that ubiquitination of p 2 l was prevented by mutation proteasomal degradation of p21 did not require p21 of the lysines. Surprisingly, p21 K6R not only remained ubiquitination. First, we utilized a ubiquitin mutant unstable, but its abundance also increased in response (UbR7) lacking lysines that inhibits multiubiquitination to proteasome inhibition indistinguishably from wildof cyclin B, but not monoubiquitination (T. McGarry, type p21 ( Figure 2C ). Furthermore, the half-life of both personal communication). As a control, cotransfection wild-type p21 and p21 K6R increased from less than of this mutant ubiquitin increased the steady-state 30 min to greater than 2 hr after proteasome inhibition abundance and half-life of cyclin E, a substrate of the ( Figure 2D ). cullin family of E3 ubiquitin ligases (Clurman et al., 1996;  In parallel, we also examined the degradation of a Won and Reed, 1996; Dealy et al., 1999; Singer et al., lysineless mutant of cyclin E (cyclin EAK). Mutating all 1999; Wang et al., 1999) (Figure 2A ). In contrast, overexof the lysines in cyclin E prevented formation of cyclin pression of UbR7 did not increase the abundance of E-ubiquitin conjugates ( Figure 2E ). However, unlike p21, p21. These data suggest that direct multiubiquitination the abundance of cyclin EAK was no longer responsive is required for cyclin E degradation, but not for p21, to proteasome inhibition, consistent with a major role although we cannot rule out the possibility that cyclin for ubiquitination in cyclin E turnover. E and p 2 l are differentially sensitive to conjugation with Third, we examined the role of p21 ubiquitination unUbR7.
der more physiologic conditions utilizing stable retroviSecond, we mutated all six lysines in p21 (the sites rally transduced cell lines. The retroviral p21 was of of potential ubiquitin conjugation) to arginine (p21 K6R).
human origin and introduced into mouse cells, allowing p21 K6R bound, inhibited, and was phosphorylated by us to specifically monitor expression of the exogenous cyclin-Cdk complexes like wild-type p21, indicating that and endogenous p 2 l proteins by using species-specific its structure and activity were not severely affected by antibodies and the different electrophoretic mobilities of human and mouse p21 (see Experimental Procewith Mg-132 or 13-lactone increased the steady-state dures). We directly compared the abundance of the exaccumulation of both proteins as assayed by Western ogenous wt-p21 to endogenous mouse p 2 1 in the same blotting and by indirect immunofluoresence (Figures 3C cell population and found that the exogenous p21 was and 3E and data not shown). Additionally, the half-lives expressed at levels equal to or less than endogenous of p21 K6R and endogenous mouse p21 were almost p21 ( Figure 3A) . We next observed that the exogenous indistinguishable within the same cells ( Figure 3D ). Thus, wt-p21 and p21 K6R were expressed at similar levels the turnover of p21 K6R mirrored that of wild-type p21 in the respective cell pools and that the infected cells under near-physiologic expression conditions. proliferated normally, consistent with the observed levFourth, in rare cases, ubiquitin can be conjugated to els of expression ( Figures 3A-3C and data not shown).
proteins via the N-terminal a-NH2 group, although most Furthermore, the retroviral wt-p21 and p21 K6R bound mammalian proteins are N" acetylated, and their N terto similar amounts of endogenous Cdk2, indicating that mini cannot be ubiquitinated (Brown, 1979 ; Hershko et both proteins were incorporated into Cdk-complexes al., 1984; Tsunasawa and Sakiyama, 1984) . The N termiequivalently ( Figure 3B) . nus was recently identified as the key ubiquitination We then measured turnover of the retrovirally exsite for the MyoD protein (Breitschopf et al., 1998 LNSX-p21 K6R cells were stained with monoclonal anti-21 (Transduction Labs) (right panel). Mg-132 treatment is indicated. The endogenous mouse p21 is detected by polyclonal but not monoclonal anti-p21 and is sensitive to proteasome inhibition. The exogenous human p21K6R is detected by monoclonal anti-p21 and is similarly responsive to proteasome inhibition.
p21 K6R is not. Additional evidence that N-terminal ubi-N-terminal p 2 l fusion proteins remained sensitive to quitination is not important for p21 turnover was obproteasome inhibition. tained by N-terminal epitope tagging p21 and p21 K6R. This manipulation was previously shown to stabilize MyoD in vivo by preventing its amino-terminal ubiquitinaRegulation of p21 Turnover tion (Breitschopf et al., 1998) . However, the abundance
We have begun to address the mechanisms that might and half-life of the N-terminal p21 fusion proteins redirect p21 to the proteasome, if it is not via direct ubiquimained sensitive to proteasome inhibition (Figures 4A tination. These experiments have revealed that proteaand 4B). Furthermore, the N termini of human p21, musomal turnover of p21 depends upon its localization to rine p21, myc-p21 and HA-p21 (Met-Ser, Met-Ser, Metthe nucleus. A p 2 l C-terminal truncation mutant lacking Gly, and Met-Ala, respectively) all contain residues most its nuclear localization signal, p21 (1-141), differed from frequently found in N-acetylated proteins (Tsunasawa wild-type p21 in two respects; it accumulated almost and Sakiyama, 1984; Bradshaw et al., 1998) . Therefore, exclusively in the cytoplasm ( Figure 4C ), and its abun-N-terminal ubiquitin conjugation is unlikely to be the dance was largely insensitive to proteasome inhibition mechanism of p21 turnover since deletion of the p21 ( Figure 4D ). To address the possibility that deletion of lysines eliminates p21-ubiquitin conjugate formation, inthe C-terminal 25 amino acids removed an "instability" dicating that ubiquitin is not attached to another site on sequence, we added an SV40 NLS to p21(1-141) to redithe protein, and since the abundance and stability of rect ittothe nucleus. The readdition of an NLS effectively A. mt-B. retargeted p21 (1-141) to the nucleus, and the protein vivo are insufficient to conclude that protein turnover regained its proteasome sensitivity, must proceed through a ubiquitinated intermediate. In these respects, the turnover of p21 differs markedly How might p21 be degraded by the proteasome indefrom its close relative p27Kipl, which has been shown to pendently of ubiquitin attachment? The clearest exambe degraded in the cytoplasm. Furthermore, the nuclear pie of a protein whose turnover by the proteasome is export of transfected p27 is blocked by both proteaubiquitin independent is ornithine decarboxylase (ODC), some inhibitors and the nuclear export inhibitor leptoand additional examples have been proposed (Muramycin B, thereby sequestering p27 in a cellular compartkami et al., 1992; Jariel-Encontre et al., 1995; Yu et al., ment where it is relatively stable (the nucleus) (Tomoda 1997) . ODC is directed to the proteasome by its specific et al., 1999). In contrast, we find that p21 is degraded binding partner, antizyme. Similarly, the interaction of in the nucleus but is relatively stable in the cytoplasm. p21 with its known binding partners affects its turnover, Furthermore, we have not observed any effect of leptoalthough these relationships are complex and poorly mycin B on the abundance of transfected p21 (data not understood (Cayrol and Ducommun, 1998 ; Rousseau et shown). Thus, unlike p27, proteasome inhibition does al., 1999; unpublished observations). Perhaps the simnot indirectly stabilize p21 by restricting it to a cellular plest explanation is that nonubiquitinated p21 is directly compartment where it is stable. recognized by the proteasome. Unstructured proteins can be directly recognized and degraded by proteaDiscussion somes in vitro and in vivo without ubiquitination (Katznelson and Kulka, 1985; Wenzel and Baumeister, 1993 ; p21 is an unstable protein exhibiting proteasome-sensi- Michalek et al., 1996) . Moreover, free p21 does not have tive turnover and ubiquitination in vivo. However, we a well-defined tertiary structure (Kriwacki et al., 1996 , have shown that p21 remains unstable and proteasome 1997). Thus, p21 and perhaps other small Cdk inhibitors dependent even when it cannot be ubiquitinated. Theremight be directly recognized by the proteasome when fore, direct p21-ubiquitin conjugates are not obligatory they are free of cyclin/Cdk complexes and adopt unintermediates in proteasome-dependent p21 turnover, structured conformations. These data do not exclude the possibility that p21 turn-
The presence of ubiquitinated p21 suggests that p 2 l over may be mediated by ubiquitination in some physiois associated with ubiquitinating enzymes. An interestlogic contexts. Alternatively, p21 ubiquitination may ing possibility is that p 2 l may be recruited to the proteaserve some function other than signaling proteolysis. some by being bound to a protein that is itself ubiquitiRegardless, the example of p21 illustrates that observnated. Components of the SCF, an E3 ubiquitin ligase ing multiubiquitination and proteasome sensitivity in that regulates the abundance of G1 cyclins and Cdk inhibitors in yeast, are themselves ubiquitinated (Zhou and recombined with either pHM200-myc3 or pHM200-HA3. p21 (1-and Howley, 1998; Galan and Peter, 1999) , and mamma-141) and p21(1-141NLS) were produced by generating PCR fraglian homologs of SCF proteins have been identified (Pements beginning with the p21 ATG and ending at either residue 141, or adding KKKRKV (corresponding to the SV40 NLS) after residue ters, 1998; Koepp et al., 1999) . In fact, p 2 l has been 141, and subcloned into pCS2 or pCS2MT (myc-tagged) and sereported to physically interact with complexes conquenced.
taining SCF proteins, and antisense inhibition of SCF proteins leads to p21 overaccumulation in vivo (Yu et al., Antibodies 1998; Yam et al., 1999) . Thus, perhaps p21 is recruited to The following antibodies were used: monoclonal anti-p21 (Transthe proteasome through its physical association with a duction Labs); polyclonal anti-p21 antibody (Cl 9), monoclonal antiubiquitinated E3 complex.
p21 antibody (F5), and anti-Cdk2(M2), (Santa Cruz Biotechnology); Finally, we cannot exclude the possibility that proteamonoclonal anti-human cyclin E HE12 (Pharmingen), HRP-conjugated anti-mouse and anti-rabbit IgG (Amersham), FITC-anti mouse some inhibitors affect p21 turnover indirectly. For inIgG, or anti-rabbit IgG (Jackson Labs). 9E10 (anti-myc tag) was stance, proteasome inhibition may indirectly stabilize prepared by an in-house facility.
p21 by affecting protein(s) that regulate p21 abundance. Polyclonal anti-p21(C-19) detects both mouse and human p21
Thus, p21 might be stable when bound to a protein that and was used to directly compare the expression of retrovirally is itself proteasome dependent, or a p21 protease may expressed wild-type human p21 and endogenous mouse p21. Bebe regulated by the proteasome, cause the epitope recognized by this antibody contains lysines, it detects p21 K6R poorly (see Figure 3A) . Monoclonal p21 (TransducDefining the role of the ubiquitin-proteasome system tion Labs), which recognizes only human p21, was thus used to in protein turnover is complicated by its involvement in compare the level of wt-p21 to p21K6R expression and allows an diverse biological processes. In the case of p21, our indirect comparison of p21 K6R and endogenous p21 expression. importance of direct ubiquitination in proteasomal pro-NP-40, 1% deoxycholate, 0.1 % SDS, 10 ýLg/ml each of aprotonin, tein degradation has not yet been determined. leupeptin, and pepstatin, 50 mM NaF, 1 mM Na vanadate), followed by scraping and sonication. Lysates for coimmunoprecipitation were made in NP-40 buffer (0.5% NP-40, 20 mM Tris [pH 7.4], 150 Experimental Procedures mM NaCi). Cell extracts were electrophoresed on 12%-17% polyCell Culture and Transfections acrylamide gels and Western blotted was as described (Clurman et al., 1996) . For immunoprecipitation, cell lysates normalized for proHuman diploid fibroblasts were provided by C. Grandori (Seattle, tein concentration were processed as described (Clurman et al., WA); NIH3T3 and 293 cells were previously described (Sheaff et 1996) . Forthe p2l kinase assay, afterthe last wash, immunoprecipial., 1997). All cell lines were grown and transfected as described tates were resuspended in 20 I kinase buffer containing 1 1 im previously (Clurman et al., 1996) . In most experiments, DNA concen-ATP ± 0.5 pLl [ 3 y_ 2 P]ATP (6000 Cl/mM, NEN) and incubated at 37oC tration was 6 Rg/60 mm dish. Different experimental conditions are for 30 min. noted. For wt-p21, p21-K6R, and p21 (1-141), NIH 3T3 cells and 293 cells were transfected with 2 ig and 1 Rg of expression vector/ 60 mm dish, respectively, whereas 250 ng/6Omm dish of mt-p21, Pulse-Chase mt-p21 K6R, and HA-p21 vectors was used. For endogenous p21, cells in 100 mm dishes were labeled with Tran 35 label (ICN) at 500 iCi/ml in 2.2 ml DME without methionine/ Plasmids, In Vitro Mutagenesis, and Retroviral Vectors cysteine (ICN) for 15 min at 37°, then chased with DME/10% FBS Plasmids were obtained from: pHA-ubiquitin (M. Treier, Heidelberg, with 400 mg/L methionine. Cells were lysed in RIPA and immunopreGermany); p-CMV-CDK2 (E. Harlow, Charlestown, MA); pUBR7 (T. cipitated with polyclonal anti-p21 antibody (C-19) after preclearing.
McGarry, R. King, and M. Kirschner, Boston, MA); pUNI1 5, pHM200-Modifications for transfected p21 were as follows: first, cells were myc3, and pHM200-HA3 (S. Elledge, Houston, TX); and pLNSX (D. transfected on 70%-80% confluent 100 mm dishes, and each dish Miller, Seattle, WA). pCS2hp21, pCS2mt-cyclin E (M1 30A), pCS2mt-was split into 6-8 60 mm dishes so that each time course was cyclin E, and pCS2mt-cyclinA were previously described (Clurman derived from the same transfection; second, 200 pCi/ml of label et al., 1996) . CS2-p21 K6R and CS2-MTEAK were constructed from was used, and half of each 60 mm plate lysate immunoprecipitated pCS2p21 and pCS2m-cyclin E by converting all of the lysine residues with monoclonal anti-p21 (Transduction Labs). For pulse-chase in each protein to arginine as described (Clurman et al., 1996) . Primer analyses after proteasome inhibition, cells were treated with MGsequences are available upon request. 132 or 3-lactone for 2 hr prior to labeling, and inhibitors were present For LNSX-p21 and LNSXp21 K6R viral stocks, the CS2 p21 and throughout all subsequent stages. Pulse-chase analyses of NIHp21K6R inserts were subcloned into the retroviral vector pLNSX LNSXp21 and NIH-LNSXp21 K6R were performed as described for (Miller and Rosman, 1989) . Retroviral supernatants were prepared endogenous p21, and lysates immunoprecipated with monoclonal by transfecting the producer line Phoenix-Eco (obtained from G. anti-p21 (Transduction Labs) or monoclonal anti-p21 F5 (Santa Cruz).
Nolan, Palo Alto, CA.) with pLNSX-p21 and pLNSX-p21 K6R and harvesting supernatants after 48 hr. 500,000 NIH3T3 cells were Indirect Immunofluoresence transduced with 3 ml of viral supernatant and selected with G418 NIH3T3 or HeLa cells were transfected as above with glass cov-(3 mg/ml). erslips in the dish. Cells were fixed in 4% paraformaldehyde, permeThe HA3-p21, HA3p21 K6R, mt3p21, and mt3p2l K6R constructs abilized with 0.1 % Triton X-1 00/PBS, then stained with primary antiwere made with the Univector system as described (Liu et al., 1998) .
body followed by FITC-anti-mouse IgG or FITC-anti-rabbit IgG The cDNAs of human p21 and p21 K6R were subcloned into pUNI1 5 (Jackson Labs). The final wash contained DAPI to visualize nuclei.
